Group 1 - The core viewpoint of the article highlights the significant stock price surge of Baize Medical (2609.HK), which rose over 50% in one day and further increased by 94% to reach HKD 19.88, marking a total increase of 192% over two days, with a market capitalization exceeding HKD 26 billion [1] - Baize Medical is primarily engaged in investment and provision of medical services related to oncology, operating six proprietary for-profit hospitals and managing two non-profit hospitals across various regions including Beijing, Tianjin, and Anhui [1] - The company’s flagship hospital is Beijing Xiyuan Cancer Hospital, which offers core services such as cancer screening, diagnosis, treatment, and rehabilitation [1] Group 2 - The inclusion of Baize Medical in the Hong Kong Stock Connect program, effective from September 8, has contributed to its stock price surge [1]

Group 1 - The stock price of Sanbo Brain Science closed at 66.16 yuan on August 19, 2025, down 1.02% from the previous trading day, with a trading volume of 1.576 billion yuan [1] - The stock experienced significant volatility, with a fluctuation range of 6.18% after a quick rebound in the morning followed by a pullback [1] - Sanbo Brain Science operates in the medical services sector, focusing on brain-related medical fields, including diagnosis, treatment, and rehabilitation services, aiming to provide precise medical solutions [1] Group 2 - On August 19, 2025, the net outflow of main funds for Sanbo Brain Science was 45.8035 million yuan, with a cumulative net outflow of 333 million yuan over the past five days, indicating a short-term trend of capital outflow [1]

Core Viewpoint - Sanbo Brain Science's stock price increased to 50.08 yuan as of July 31, 2025, reflecting a rise of 1.73 yuan from the previous trading day, indicating positive market sentiment towards the company [1]. Company Overview - Sanbo Brain Science specializes in the medical services sector focused on neurosurgery, providing diagnosis, treatment, and rehabilitation services for brain diseases [1]. - The company operates medical institutions in Beijing and covers niche areas such as precision medicine [1]. Market Activity - On July 31, the stock experienced a rapid rebound, with a price increase of over 2% within a 5-minute window from 14:45 to 14:50 [1]. - The trading volume for the day was 145,676 hands, with a total transaction amount reaching 719 million yuan [1]. - There was a net inflow of 27.91 million yuan from major funds on that day, suggesting strong investor interest [1].